| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.17 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.17 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |